SETD2 and nonpapillary renal cell carcinoma: Moreover, while VHL, PBRM1, SETD2, and BAP1 mutations are the most dominant in ccRCC, mutations of MET, SETD2, NF2, TP53, and PTEN are more common in papillary RCC and chromophobe RCC, respectively [17].